IPO registrations (S-1, F-1) · Registrants
Zosano Pharma Corp
- SEC CIK
- 1587221 · filings on EDGAR ↗
- Former names
- ZP Holdings Inc (2013–2014)
- Registration
- Form S-1, first filed 2014-06-24, last 2018-03-28; 4 initial registrations, 14 amendments
- Outcome
- Final prospectus filed 2015-01-27; declared effective 2015-01-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 34790 ARDENTECH COURT, Fremont, CA 94555
- EIN
- 45-4488360
- EDGAR entity type
- operating
- Insiders and CEO pay
- Zosano Pharma Corp on the corporate pages
Offering terms
- Proposed price range
- $10.00–$12.00 per share (S-1/A filed 2015-01-26)
- Final price
- $11.00 per share, within the range (424B4 filed 2015-01-27, an initial public offering)
- Shares sold
- 4,500,000
- Gross proceeds
- $49,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ZSAN
- Lead underwriters
- Ladenburg Thalmann (2,250,000 shares); Roth Capital Partners (2,250,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ZOSANO PHARMA CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: ZOSANO PHARMA CORP. EXACT (EIN (EXACT))
- Form D issuer: Zosano Pharma Corp EXACT (CIK (EXACT))
- SEC filer: Zosano Pharma Corp EXACT (CIK (EXACT))
- Person page: Krishna Kittu Kolluri Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
Filings 27
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-06-24 | S-1 | S-1 (registration) | Zosano Pharma Corp | 0001193125-14-246169 ↗ |
| 2014-07-16 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-14-270452 ↗ |
| 2014-07-17 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-14-271748 ↗ |
| 2014-07-25 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-14-280670 ↗ |
| 2014-07-29 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-14-283386 ↗ |
| 2014-12-10 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-14-439043 ↗ |
| 2015-01-09 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-15-006670 ↗ |
| 2015-01-20 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-15-015033 ↗ |
| 2015-01-26 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-15-019410 ↗ |
| 2015-01-26 | EFFECT | EFFECT (declared effective) | Zosano Pharma Corp | 9999999995-15-000195 ↗ |
| 2015-01-27 | 424B4 | 424B4 (final prospectus) | Zosano Pharma Corp | 0001193125-15-021882 ↗ |
| 2016-09-23 | EFFECT | EFFECT (declared effective) | Zosano Pharma Corp | 9999999995-16-005768 ↗ |
| 2017-03-02 | S-1 | S-1 (registration) | Zosano Pharma Corp | 0001193125-17-067983 ↗ |
| 2017-03-13 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-17-079412 ↗ |
| 2017-03-17 | EFFECT | EFFECT (declared effective) | Zosano Pharma Corp | 9999999995-17-000585 ↗ |
| 2017-03-20 | 424B4 | 424B4 (final prospectus) | Zosano Pharma Corp | 0001193125-17-089468 ↗ |
| 2017-11-13 | S-1 | S-1 (registration) | Zosano Pharma Corp | 0001193125-17-341134 ↗ |
| 2017-11-21 | EFFECT | EFFECT (declared effective) | Zosano Pharma Corp | 9999999995-17-003047 ↗ |
| 2017-12-22 | S-1 | S-1 (registration) | Zosano Pharma Corp | 0001193125-17-377660 ↗ |
| 2018-01-29 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-18-022387 ↗ |
| 2018-02-06 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-18-032474 ↗ |
| 2018-02-13 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-18-040699 ↗ |
| 2018-03-26 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-18-094912 ↗ |
| 2018-03-28 | S-1/A | S-1/A (amendment) | Zosano Pharma Corp | 0001193125-18-098083 ↗ |
| 2018-03-28 | EFFECT | EFFECT (declared effective) | Zosano Pharma Corp | 9999999995-18-000698 ↗ |
| 2018-03-29 | 424B1 | 424B1 (final prospectus) | Zosano Pharma Corp | 0001193125-18-102019 ↗ |
| 2019-03-27 | EFFECT | EFFECT (declared effective) | Zosano Pharma Corp | 9999999995-19-000534 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-01-26 | S-1/A | registration statement | $10.00–$12.00 | $11.00 | 4,300,000 | $47,300,000 | Nasdaq ZSAN | 4 | primary document; range, price sentence, shares headline, proceeds computed, underwriting table 2, cover names 2 | document ↗ |
| 2015-01-27 | 424B4 | final prospectus | $11.00 | 4,500,000 | $49,500,000 | Nasdaq ZSAN | 2 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARRETT M JAMES | Director,TenPercentOwner; TenPercentOwner | 9 | 2015–2017 | ||
| BARRIS PETER J | TenPercentOwner | 9 | 2015–2017 | ||
| BASKETT FOREST | TenPercentOwner | 9 | 2015–2017 | ||
| BioMed Realty L P | TenPercentOwner | 2 | 2015 | ||
| BioMed Realty Trust Inc | TenPercentOwner | 2 | 2015 | ||
| Daddona Peter E. | Director,Officer | Chief Scientific Officer | 1 | 2015 | |
| DRANT RYAN D | TenPercentOwner | 2 | 2015 | ||
| KERINS PATRICK J | TenPercentOwner | 9 | 2015–2017 | ||
| KOLLURI KRISHNA KITTU | TenPercentOwner | 8 | 2015–2016 | person page Fuzzy | |
| Lamba Vikram | Director,Officer,TenPercentOwner | President, CEO | 1 | 2015 | |
| NEA 12 GP, LLC | TenPercentOwner | 9 | 2015–2017 | ||
| NEA Partners 12, Limited Partnership | TenPercentOwner | 9 | 2015–2017 | ||
| New Enterprise Associates 12, Limited Partnership | TenPercentOwner | 9 | 2015–2017 | ||
| Oza Nandan | Officer | Chief Operating Officer | 1 | 2015 | |
| SANDELL SCOTT D | TenPercentOwner | 9 | 2015–2017 | ||
| Steel Bruce D. | Director | 1 | 2015 | ||
| Strange Alexander Ramsay | Officer | VP, Strategy & Corp. Develop. | 1 | 2015 | |
| Tso Winnie Wing-Kei | Officer | Chief Financial Officer | 4 | 2015–2017 | |
| WILSON TROY EDWARD | Director | 6 | 2015–2019 | ||
| XANTHOPOULOS KLEANTHIS G | Director | 10 | 2015–2021 | ||
| LILLY ELI & CO | TenPercentOwner | 1 | 2015 | ||
| Peri Laxmi | Officer | Sr. Vice President, Operations | 3 | 2015 | |
| Hagan Joseph P | Director | 9 | 2015–2021 | ||
| Alataris Konstantinos | Director,Officer; Officer | President; President, CEO | 7 | 2015–2017 | |
| WALKER JOHN PETER | Director; Director,Officer | Interim CEO; President and CEO; President & CEO | 13 | 2016–2020 | |
| Erbez Georgia | Officer | CBO and Interim CFO; CFO and Chief Business Officer; Interim CFO | 4 | 2016–2017 | |
| KELLERMAN DONALD J | Officer | VP, Clinical Dev & Med Affairs | 13 | 2016–2022 | |
| Lewis Hayley | Officer | See Remarks; Senior VP, Operations; VP, Reg Affairs & QA; VP, Reg Affairs & Quality | 11 | 2016–2021 | |
| Scharin Eric | Officer | VP, Engineering & Operations | 2 | 2016 | |
| Amzak Capital Management, LLC | TenPercentOwner | 2 | 2017–2018 | ||
| Kazma Gerald J | TenPercentOwner | 2 | 2017–2018 | ||
| Kazma Michael D | TenPercentOwner | 2 | 2017–2018 | ||
| GREATHOUSE KENNETH | Director | 13 | 2017–2021 | ||
| Aisling Capital IV, LP | TenPercentOwner | 4 | 2018–2019 | ||
| ELMS STEVE | Director; Director,TenPercentOwner; TenPercentOwner | 9 | 2018–2021 | ||
| SCHIFF ANDREW N | TenPercentOwner | 4 | 2018–2019 | ||
| Aisling Capital Partners IV LLC | TenPercentOwner | 3 | 2018–2019 | ||
| Aisling Capital Partners IV, LP | TenPercentOwner | 3 | 2018–2019 | ||
| Kitchener Gregory David | Officer | Chief Financial Officer | 5 | 2018–2019 | |
| Grais Linda | Director | 6 | 2019–2021 | ||
| Lo Steven | Director,Officer | Chief Executive Officer | 10 | 2019–2022 | |
| Matthews Christine | Officer | Chief Financial Officer; See Remarks | 9 | 2020–2022 | |
| McGee Kathy M. | Director | 2 | 2021 | ||
| Yang Elaine | Director | 2 | 2021 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-08-29 | Zosano Pharma Corp | Pharmaceuticals | $7,536,000 | $7,536,000 | 18 | 1 |
| 2015-06-30 | Zosano Pharma Corp | Pharmaceuticals | $300,000 | $0 | 1 | 1 |
| 2015-02-03 | Zosano Pharma Corp | Pharmaceuticals | $15,000,000 | $14,999,996 | 1 | 1 |
| 2014-12-04 | Zosano Pharma Corp | Pharmaceuticals | $2,000,000 | $1,333,000 | 2 | 1 |
| 2014-03-05 | ZP Holdings Inc | Pharmaceuticals | $2,500,000 | $2,500,000 | 3 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ZOSANO PHARMA CORPORATION | CA | State business registries | name and state |
| Plan sponsor | ZOSANO PHARMA CORP. | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | Zosano Pharma Corp | CA | Form D private offerings | CIK (EXACT) |
| Patent assignee | Zosano Pharma Corporation | CA | Patents (USPTO) | name and state |
| SEC filer | Zosano Pharma Corp | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Zosano Pharma Corporation | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ZOSANO PHARMA CORP. | EIN (EXACT) | ||
| Person page | Krishna Kittu Kolluri | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CA first:
- NovaCardia Inc CA
- MyoKardia, Inc. CA
- Bioquest Corp CA
- Regen BioPharma Inc CA
- CONNETICS CORP CA
- SIBIA NEUROSCIENCES INC CA
- MEDIVATION, INC. CA
- IMMUSOL INC CA
- DYNAVAX TECHNOLOGIES CORP CA
- Diadexus, Inc. CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health